Literature DB >> 4104337

Cyclophosphamide in lupus nephritis: a controlled trial.

A D Steinberg, H B Kaltreider, P J Staples, E J Goetzl, N Talal, J L Decker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 4104337     DOI： 10.7326/0003-4819-75-2-165

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  33 in total

1.  Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.

Authors:  J S Cameron; M H Lessof; C S Ogg; B D Williams; D G Williams
Journal:  Clin Exp Immunol       Date:  1976-09       Impact factor: 4.330

Review 2.  Combination treatment in autoimmune diseases: systemic lupus erythematosus.

Authors:  G Moroni; O Della Casa Alberighi; C Ponticelli
Journal:  Springer Semin Immunopathol       Date:  2001

3.  Editorial: Immunosuppressive therapy in SLE-a reappraisal.

Authors: 
Journal:  Br Med J       Date:  1976-04-10

4.  The epidemiology of systemic lupus erythematosus: 1950-1990 conceptual advances and the ARAMIS data banks.

Authors:  J F Fries
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  Regulation of secondary antibody responses in rodents. I. Potentiation of IgG production by cyclophosphamide.

Authors:  R F Gagnon; I C MacLennan
Journal:  Clin Exp Immunol       Date:  1979-07       Impact factor: 4.330

6.  Childhood lupus nephritis: 12 years experience from North India.

Authors:  Surjit Singh; Ranjana Minz; Ritambhra Nada; Kusum Joshi
Journal:  Rheumatol Int       Date:  2006-05       Impact factor: 2.631

Review 7.  Treatment of lupus nephritis.

Authors:  Fayez F Hejaili; Louise M Moist; William F Clark
Journal:  Drugs       Date:  2003       Impact factor: 9.546

8.  Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases.

Authors:  P Hollingworth; A de Vere Tyndall; B M Ansell; T Platts-Mills; J M Gumpel; J Mertin; D S Smith; A M Denman
Journal:  Ann Rheum Dis       Date:  1982-12       Impact factor: 19.103

Review 9.  Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.

Authors:  Virginia Fernandes Moça Trevisani; Aldemar A Castro; João Ferreira Neves Neto; Alvaro N Atallah
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

10.  Successful treatment of autoimmune disease in (NZB/NZW)F1 female mice by using fractionated total lymphoid irradiation.

Authors:  S Slavin
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.